🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
The main purpose of this study is to determine whether adding SurVaxM to st...
Status
Unknown
Location
University of California
Start Date
2021-11-18
Trial ID
NCT05163080
Treatments Being Tested
This phase IIa trial compares the safety and effect of temozolomide combine...
Status
Suspended
Location
Roswell Park Cancer Institute
Start Date
2026-10-15
Trial ID
NCT06202066
RATIONALE: Drugs used in chemotherapy, such as fludarabine, work in differe...
Status
Completed
Location
Providence Cancer Center at Providence Portland Medical Center
Start Date
2004-07
Trial ID
NCT00091143
Newly diagnosed glioblastoma (GBM) patients with complete or partial surgic...
Status
Terminated
Location
The Preston Robert Tisch Brain Tumor Center at Duke
Start Date
2016-12-07
Trial ID
NCT02864368
In this study, a melanoma vaccine (5 melanoma peptides) is given with eithe...
Status
Completed
Location
NYU Clinical Cancer Center
Start Date
2005-07
Trial ID
NCT00124124
Treatments Being Tested
This phase I trial studies the side effects of vaccine therapy when given t...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2012-09-05
Trial ID
NCT01250470
Treatments Being Tested
This phase II trial studies the side effects and how well vaccine therapy w...
Status
Active Not Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2015-05-04
Trial ID
NCT02455557
Vaccine adjuvants are compounds used to increase specific immune responses ...
Status
Completed
Location
New York University Langone Medical Center
Start Date
2015-07-01
Trial ID
NCT02334735
Treatments Being Tested
This is a phase II study to determine the immunogenicity and efficacy of a ...
Status
Withdrawn
Location
NYU Perlmutter Cancer Center
Start Date
2016-11
Trial ID
NCT02754362
Treatments Being Tested